VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery s ...
Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...
Neuroscientist Kevin Hellman initially came to Endeavor Health’s Evanston Hospital to research chronic pain in the brain stem. In 2013, he collaborated with researchers from the Gynecology Research ...
The press update highlights Men Balance Pro as a formula engineered to provide structured nutritional support using botanical ...
FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026Ended 2025 with unaudited cash position of $41 ...
Magnesium shows promise in lowering blood pressure for people with hypertension who don't get enough of the mineral. However, ...
Plus, what a doctor has to say.
Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...
A study based on data from the Estonian Biobank shows that previously unstudied genetic variants may slow the breakdown of medications, leading to their buildup in the body. The risk of side effects ...
Q2 2026 Earnings Call February 4, 2026 4:30 PM ESTCompany ParticipantsSteven Fife - President, CEO & DirectorCarl Aure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results